Skip to main content
. 2017 Nov 30;8(67):111309–111317. doi: 10.18632/oncotarget.22785

Table 1. Patient characteristics.

Factor Treatment
With early RT (n=49) (%) Without early RT (n=64)
EGFR-TKI alone (n=37) (%) With salvage RT (n=27) (%) P value
Age (year) 0.272
≤60 33(67) 26(70) 14(52)
>60 16(33) 11(30) 13(48)
Median(range) 54(35-80) 56(29-73) 59(33-75)
Sex 0.527
Female 30(61) 24(65) 20(74)
Male 19(39) 13(35) 7(26)
ECOG performance status 0.132
0-1 37(75) 34(92) 21(78)
≥2 12(25) 3(8) 6(22)
Symptomatic from BM <0.001
No 10(20) 32(87) 18(67)
Yes 39(80) 5(13) 9(33)
Number of BMs 0.162
≤3 12(25) 4(11) 3(11)
>3 37(75) 33(89) 24(89)
DS-GPA 0.001
0-2.0 42(86) 19(51) 22(81)
2.5-4.0 7(14) 18(49) 5(19)
Brain radiation 0.550
WBRT 37(76) - 22(81)
SRS 12(24) - 5(19)
Smoking status 0.606
Never or light smoker 37(76) 30(81) 19(70)
Heavy smoker 12(24) 7(19) 8(30)
EGFR mutations 0.222
19-del 20(41) 17(46) 9(33)
L858R 19(39) 18(49) 15(56)
Unknown 10(20) 2(5) 3(11)

Abbreviations: EGFR=epidermal growth factor receptor; TKI=tyrosine kinase inhibitor; BM=brain metastasis; DS-GPA= Disease-specific Graded Prognostic Assessment; ECOG=Eastern Cooperative Oncology Group; WBRT= whole brain radiotherapy; SRS= stereotactic radiosurgery; Never smoker= patient who had smoked less than 100 cigarettes during their lifetime; Light smoker=patient who had smoked less than 10 packs a year.